Saturday, November 14, 2026 | 07:06 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

FPIs rotate out of rate-sensitive sectors amid high interest rates

Financials see sharpest outflows as investors favour pharma, consumer services

image

Financial services recorded the sharpest FPI outflows during the month, with investors selling shares worth ₹13,147 crore, compared with inflows of ₹10,494 crore in the previous month. (Illustration: Binay Sinha)

Kairavi Lukka Mumbai

Listen to This Article

Overseas investors turned net sellers of Indian equities in September, offloading shares worth ₹35,861 crore and ending a two-month buying streak in July and August, according to data from the National Securities Depository. They had bought ₹29,631 crore worth of shares in August.
 
Foreign portfolio investors (FPIs) shifted their preferences during the month, moving away from interest rate-sensitive sectors such as banking, automotive, and oil and gas. Of the 24 sectors tracked, nine recorded inflows in September, while 14 saw outflows. The healthcare and pharmaceutical sectors recorded inflows, although domestic institutions accounted for a larger share of the buying than foreign institutional investors (FIIs).
 
 
Financial services recorded the sharpest FPI outflows during the month, with investors selling shares worth ₹13,147 crore, compared with inflows of ₹10,494 crore in August. This was followed by net selling of ₹3,000-6,900 crore in fast-moving consumer goods, metals and mining, telecommunications, automotive and automotive components, and oil, gas and consumable fuels. In contrast, consumer services attracted the highest inflows in September, at ₹2,333 crore. 
 
A report from SBI Securities said that amid global macroeconomic challenges in 2026, including high global interest rates, geopolitical tensions, and rupee volatility, foreign investors might be treating consumer services as a defensive buffer.
 
“India’s expanding middle-class demographic continues to drive strong growth in discretionary spending,” the report said. “Segments such as travel and tourism, hospitality and food services, retail and ecommerce remain highly underpenetrated compared with developed markets, presenting long-term opportunities that institutional capital seeks.”
 
Healthcare and pharmaceutical are generally considered defensive sectors because demand for medicines tends to be relatively inelastic, even during periods of high inflation or economic uncertainty. This defensive nature can also support higher price-to-earnings (P/E) multiples.
 
Over the past two months, as oil prices have risen and interest rates have remained high, institutional investors have increased their exposure to relatively expensive sectors such as pharmaceutical. They have been selling public-sector banks, which trade at around 7x earnings, oil and gas companies at around 11x and metals at around 17x, while buying pharmaceutical stocks, where the average P/E multiple is around 41x.
 
SBI Securities said the sector recorded net cumulative FII inflows of ₹2,117 crore in September 2026, following more than ₹13,600 crore of inflows over the previous two months, indicating sustained buying interest.
 
“The three months of consistent buying comes after a prolonged phase of sustained outflows from April 2025 to June this year, suggesting a gradual shift in investor positioning towards the sector,” it said.
 
Sectoral trends also changed between the first and second halves of September. Compared with the first half of the month, FPIs bought more equities in consumer services and textile and turned buyers from sellers in real estate. However, selling intensified in several sectors, including metals and mining, telecommunications, automotive and automotive components, oil, gas and consumable fuels, financial services, construction material, capital goods, and consumer durables.

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 07 2026 | 7:27 PM IST